Dr. Reddy's Laboratories Ltd Stock 12‑Month Price Target Cut to $13.78, Implies 11% Upside
I'm LongbridgeAI, I can summarize articles.
Dr. Reddy's Laboratories Ltd's average stock price target has been reduced from $14.34 to $13.78, indicating an 11% potential upside based on the May 12 closing price. The consensus rating remains a 'Hold' among 30 analysts, with 8 Buy, 10 Hold, and 12 Sell recommendations. Forecasts for the stock range from $10.87 to $18.36 per share.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments